SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation

SIU-ICUD: Germline Genetic Susceptibility to Prostate Cancer: Utility and Clinical Implementation

<b>Background/Objectives:</b> Prostate cancer is the most common cancer among men globally and a leading cause of cancer-related death. Germline genetic evaluation is increasingly recognized as essential for men with high-risk features such as a strong family history or advanced disease....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: James T. Kearns, Annabelle Ashworth, Elena Castro, Rosalind A. Eeles, Liesel M. FitzGerald, Peter J. Hulick, Stacy Loeb, Christian P. Pavlovich, Timothy R. Rebbeck, Susan T. Vadaparampil, Zhuqing Shi, Huy Tran, Jun Wei, Jianfeng Xu, Brian T. Helfand
Format: Article
Langue:anglais
Publié: MDPI AG 2025-06-01
Collection:Société Internationale d’Urologie Journal
Sujets:
prostate cancer
genetics
polygenic risk score
personalized medicine
clinical implementation
Accès en ligne:https://www.mdpi.com/2563-6499/6/3/45
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Connectez-vous pour connaître les informations sur les réservations

Internet

https://www.mdpi.com/2563-6499/6/3/45

Documents similaires